They are derived from patterns observed across hundreds of trial participants and from the pharmacological profile of the drug
Third-party testing is recommended for critical applications
This covers consultation with a licensed medical provider, the compounded medication at appropriate doses, all injection supplies (syringes, needles, alcohol pads, sharps container), cold-chain shipping to maintain medication stability, monthly follow-up appointments and dose adjustments, and ongoing access to medical support
Multiple classifications for the various forms of AN have been published, but they have not proven to be of much help clinically, and in any event, there is no agreement on which approach should be used
While tirzepatide appears generally safe, some individuals should avoid it: People with advanced CKD or on dialysis should consult their doctor before using it